U.S. payer budget impact of using an AI-augmented cancer risk discrimination digital histopathology platform to identify high-risk of recurrence in women with early-stage invasive breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

U.S. payer budget impact of using an AI-augmented cancer risk discrimination digital histopathology platform to identify high-risk of recurrence in women with early-stage invasive breast cancer

Published:2024-07-25 Issue:1 Volume:27 Page:972-981
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Masud Salwa F.¹,Mark Noah¹,Goss Thomas¹^ORCID,Malinowski Doug²,Schnitt Stuart J.³,Sparano Joseph A.⁴,Donovan Michael J.²^ORCID

Affiliation:

1. Veranex, Raleigh, NC, USA

2. PreciseDx, New York, NY, USA

3. Brigham and Women’s Hospital, Dana-Farber/Brigham and Women’s Cancer Center, Boston, MA, USA

4. Division of Hematology and Medical Oncology, Ichan School of Medicine, Mount Sinai Health System, New York, NY, USA

Funder

PreciseDx

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2024.2379211

Reference38 articles.

1. American Cancer Society. Breast cancer facts and statistics 2024; 2024 [cited 2024 Jan 2]. Available from: https://www.breastcancer.org/facts-statistics.

2. Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

3. NCCN Guidelines® Insights: Breast Cancer, Version 4.2023

4. Oncotype DX breast recurrence score test│ precision oncology; 2024 [cited 2024 Jan 2]. Available from: https://precisiononcology.exactsciences.com/healthcare-providers/treatment-determination/breast-cancer/oncotype-dx-breast-recurrence-score.

5. Breast Cancer Statistics, 2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP